The aging bladder by Bruschini, Homero
Rev Med (São Paulo). 2018 May-June;97(3):320-2.
320
doi: http://dx.doi.org/10.11606/issn.1679-9836.v97i3p320-322
The aging bladder
O envelhecimento vesical
Homero Bruschini
Bruschini H. The aging bladder / O envelhecimento vesical. Rev Med (São Paulo). 2018 May-June;97(3):320-2.
Departamento de Urologia, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR (Department of Urology, University 
of São Paulo, São Paulo, São Paulo, Brazil). 
ORCID: https://orcid.org/0000-0002-8642-8256. Email: bruschini@uol.com.br.
Correspondence: Divisão de Urologia, Hospital das Clinicas da FMUSP. Av. Dr. Enéas de Carvalho Aguiar, 255. Cerqueira César - São 
Paulo, SP, Brazil. CEP: 05403-000.
ABSTRACT: The aging of the population is exposing patients 
and physicians to new challenging urological conditions. The 
prevalence of lower urinary tract symptoms (LUTS) increases 
significantly over the age of 65 in both sexes and severely impairs 
patients’ quality of life (QOL). A better understanding of the 
possible causes involved in this process will clarify some forms 
of treatment and stimulate new researches on this matter. The 
purpose of this review is to better describe the pathophysiological 
implications related to the aging bladder, allowing a more accurate 
management of this specific entity.
Keywords: Urinary bladder; Lower urinary tract symptoms; 
Aging.
RESUMO: O envelhecimento populacional expõe as pessoas 
a problemas urológicos desafiadores em natureza e frequência. 
A prevalência de sintomas do trato urinário inferior aumenta 
significativamente após os 65 anos de idade, em ambos os 
sexos, afetando intensamente a qualidade de vida.  Para melhor 
entendimento das possíveis causas dos processos envolvidos 
melhorará o enfoque terapêutico e estimulará pesquisas neste 
campo em crescimento.  O objetivo desta revisão é descrever os 
princípios fisiopatológicos envolvidos no envelhecimento vesical.
Descritores: Bexiga urinária; Sintomas do trato urinário inferior; 
Envelhecimento.
INTRODUCTION 
Urinary problems mean a number of symptoms, occurring since childhood to senility.  It include 
all types of incontinence, limitations to the urinary storage 
as urgency, frequency and nocturia, voiding problems as 
intermittency, slow stream and straining, post micturition 
symptoms as incomplete voiding and post micturition 
dribbling, and all combinations of these symptoms1. Lower 
urinary tract symptoms (LUTS) were introduced by Paul 
Abrams to replace the term “prostatism”, which implied that 
the prostate was responsible for most (or all) symptomatic 
voiding complaints in men2. LUTS with its subdivisions, 
filling/storage symptoms and voiding/emptying symptoms, 
have replaced the terminology of “irritative” and 
“obstructive” symptoms, both rather imprecise terms that 
imply an etiology that may be incorrect2. The prevalence 
of both storage and voiding lower urinary tract symptoms 
increases significantly over the age of 65 years in patients 
of both sexes3. Also, it is well recognized that overactive 
bladder (OAB) symptom syndrome and urodynamic 
evidence of bladder overactivity which is seen in a 
proportion of these patients increases in both sexes with 
increasing age as does detrusor underactivity and indeed 
both can co-exist in the same patient4. Furthermore there is 
a clear increasing prevalence of bladder outflow obstruction 
in the aging male population and of other disorders such 
as diabetes, cerebrovascular accidents and neurological 
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disease, all exerting an accumulative influence in the 
bladder with increasing age4. Therefore, a number of causes 
seem to affect the normal bladder/sphincter function in the 
aging process. Although LUTS cause limited risks to life 
expectancy, they severely impair patients’ quality of life, 
leading to depression, sleep deprivation, embarrassment 
and fatigue, causing a huge impact on global healthcare 
resources4. The underlying pathophysiological processes 
are poorly understood, although there is an increasing 
emphasis on the importance of both peripheral afferent 
mechanisms in the lower urinary tract as well as altered 
central transmission and processing of neural information 
from the bladder and lower urinary tract. The purpose of 
this review is to better describe the pathophysiological 
implications related to the aging bladder, allowing a more 
accurate management of this specific entity. 
Bladder wall structural changes
Structural changes in the bladder wall, including 
widespread degeneration of muscle cells and axons5 and 
decrease in the area density of smooth muscle to connective 
tissue ratio5,6, indicate that fibrosis develops in aged human 
bladder. Similarly, in aged rodents fibrosis (increased 
collagen deposition) was reported in various studies, and 
was to some extent alleviated by caloric restriction6. Obesity 
is a known risk factor for LUTS1. Hypercholesterolemic 
diet and obesity also influence adhesion molecules of 
detrusor muscle cells, potentially disturbing the spread of 
electrical signal between cells, compromising contraction7. 
Urinary obstruction also promotes bladder fibrosis6, leading 
to poor compliance and impaired bladder contraction. 
Impaired blood supply causing ischemia and reperfusion 
injury is absolutely accepted now as a neglected cause of 
bladder alterations but not yet fully understood1. Gross 
anatomical observations have shown axonal degeneration 
in human bladders and bladder from rats with induced 
ischemia4. A systematic study in rats with induced bladder 
ischemia (a risk factor in aging) has shown differential 
expression pattern for different subtypes of muscarinic 
receptors depending on the time and age after inducing 
ischemia. Ischemia in young individuals seems to promote 
overactivity and in oldies, underactivity.
Changes in bladder afferent system
The peripheral afferent limb of the micturition 
includes the urothelium and afferent nerves. Although 
the urothelial functions and urothelial-afferent nerve 
interactions play an important role in bladder sensations8, 
little is known about the influence of aging on these 
components. The oxidative stress and altered mitochondrial 
function seems to be the cause of structural studies as 
urothelial thinning, granular appearance of umbrella cell 
layer, discoidal vesicles, electron dense bodies and vacuoles 
in umbrella layer, often containing what appears to be 
cellular debris in all layers4. Changes in the urothelium can 
affect afferent neuronal input. Experiments in mice showed 
increase in the activity of afferent nerves during bladder 
filling with age, possibly consequence to increase of stretch-
induced release of acetylcholine from non-neuronal cells 
from the urothelium. A correlation with humans can explain 
the mechanism for bladder overactivity in the elderly.
It has been shown that in aged mice the activity of 
afferent nerves is augmented during bladder filling (3-4 vs. 
24 months)9. This could be due to increased stretch-induced 
release of acetylcholine (ACh) from non-neuronal cells, 
possibly from the urothelium9,10, and/or increased adenosine 
5′-triphosphate (ATP) and ACh bioavailability in the 
urothelium, as inferred from measurements of transmitter 
levels in the lumen9,10. If these findings are similar in 
humans, they could represent underlying mechanisms for 
bladder overactivity in the elderly.
Finally, there was a reduction in the number of 
small diameter fibers, predominantly unmyelinated 11. 
These changes, if occurring in humans, may account for 
alterations in bladder sensations in the elderly4.
Changes in central micturition pathways
The fact that voiding and continence are under 
forebrain control is now well established by multiple lines 
of evidence1. Some of the brain regions involved are known 
with reasonable certainty, although further investigations 
are need1. A series of diseases affecting the neurological 
system may alter this control as seen in Parkinson disease, 
dementia and other situations. The aging of the population 
even in Brazil, is exposing patients and physicians to new 
conditions that still deserve further studies and a special 
complete report12.
Changes in the efferent system 
The efferent system includes the sympathetic 
and parasympathetic nerves and the smooth muscle. The 
sympathetic system is thought to be tonically active during 
filling phase, releasing Norepinephrine (NE) to relax the 
bladder smooth muscle. The parasympathetic system is 
active during voiding and releases ACh to contract the 
bladder and nitric oxide (NO) to relax the urethra4. 
Histological studies have found a reduction of 
the sympathetic fibers in the aging rat bladder body13. 
Cystometry studies reported variable changes in micturition 
pressure, which is a measure of the efferent parasympathetic 
nerves and smooth muscle contractility14, suggesting 
changes in more than one component of the efferent system.
A decrease (∼40%) in the number of acetylcholinesterase 
(AChE)-positive neurons in the intramural plexus in older 
guinea pigs may impact the strength of the contraction and 
may lead to changes in voiding function that could account 
322
Rev Med (São Paulo). 2018 May-June;97(3):320-2.
for the underactive bladder condition15.
The purinergic component of the efferent 
transmission has been shown to be up regulated in 
conditions like aging. Decreased P2X1 mRNA expression 
in the smooth muscle in human tissue or overexpression of 
P2X3 receptor in the urothelium in male mice suggest the 
need of further detailed studies of the purinergic component 
in the process of aging.  
Changes in the immune system
Very few is known about the influence of immune 
system in the aging bladder, but it is conceivable that with 
age there is a decrease in the ability of the immune system 
to react to insults (e.g., urinary tract infections)4. This raises 
the possibility that voiding dysfunctions may be associated 
with immune and inflammatory related responses in the 
bladder and afferent system4.
CONCLUSION
The aging bladder is still a condition that deserves 
further investigation, though the knowledge we have so far 
allows us to better understand and manage elderly patients 
with lower urinary tract symptoms. It is imperative that we 
dedicate time and resources to elucidate all aspects of this 
entity, as the population gets older worldwide.
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